Literature DB >> 10554818

HHV-6-related secondary graft failure following allogeneic bone marrow transplantation.

R E Johnston1, A M Geretti, H G Prentice, A D Clark, A C Wheeler, M Potter, P D Griffiths.   

Abstract

We report the case of an 11-year-old boy who underwent allogeneic bone marrow transplantation (BMT) for relapsed acute lymphoblastic leukaemia. Despite adequate engraftment, on day 45 he developed marrow aplasia with haemophagocytosis. HHV-6 was detected in blood and bone marrow by nested PCR. Retrospective testing showed that viraemia had started on day 24. Following therapy with foscarnet and ganciclovir, viral load declined to undetectable levels and his donor marrow recovered contemporaneously. This case suggests that HHV-6 may be a treatable cause of graft failure following BMT and provides clinical and virological evidence for the anti-HHV-6 activity of ganciclovir and foscarnet.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554818     DOI: 10.1046/j.1365-2141.1999.01443.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 2.  The development of new therapies for human herpesvirus 6.

Authors:  Mark N Prichard; Richard J Whitley
Journal:  Curr Opin Virol       Date:  2014-10-22       Impact factor: 7.090

Review 3.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

4.  The comparison between the efficacy of high dose acyclovir and erythromycin on the period and signs of pitiriasis rosea.

Authors:  Amirhooshang Ehsani; Nafiseh Esmaily; Pedram Noormohammadpour; Siavash Toosi; Alireza Hosseinpour; Mahbobeh Hosseini; Shima Sayanjali
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

Review 5.  Human herpesvirus 6 infections after liver transplantation.

Authors:  Rima Camille Abdel Massih; Raymund R Razonable
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

6.  Immunomodulation and immunosuppression by human herpesvirus 6A and 6B.

Authors:  Lorenzo Dagna; Joshua C Pritchett; Paolo Lusso
Journal:  Future Virol       Date:  2013-03       Impact factor: 1.831

Review 7.  Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients.

Authors:  Duncan A Clark
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

8.  Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.

Authors:  J Kanda; M E Horwitz; G D Long; C Gasparetto; K M Sullivan; J P Chute; A Morris; T Hennig; Z Li; N J Chao; D A Rizzieri
Journal:  Bone Marrow Transplant       Date:  2011-08-01       Impact factor: 5.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.